The global Acute Respiratory Distress Syndrome (ARDS) Treatment market was valued at 367 million in 2024 and is projected to reach US$ 460 million by 2032, at a CAGR of 3.4% during the forecast period.
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks� gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Acute Respiratory Distress Syndrome (ARDS) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Acute Respiratory Distress Syndrome (ARDS) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Respiratory Distress Syndrome (ARDS) Treatment. This report contains market size and forecasts of Acute Respiratory Distress Syndrome (ARDS) Treatment in global, including the following market information:
Global Acute Respiratory Distress Syndrome (ARDS) Treatment market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Acute Respiratory Distress Syndrome (ARDS) Treatment companies in 2024 (%)
Total Market by Segment:
Global Acute Respiratory Distress Syndrome (ARDS) Treatment market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Acute Respiratory Distress Syndrome (ARDS) Treatment market segment percentages, by Type, 2024 (%)
Oral
Intravenous Injection
Intramuscular Injection
Global Acute Respiratory Distress Syndrome (ARDS) Treatment market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Acute Respiratory Distress Syndrome (ARDS) Treatment market segment percentages, by Application, 2024 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Acute Respiratory Distress Syndrome (ARDS) Treatment market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Acute Respiratory Distress Syndrome (ARDS) Treatment market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Respiratory Distress Syndrome (ARDS) Treatment revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Acute Respiratory Distress Syndrome (ARDS) Treatment revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences Inc.
Terumo Corporation
Getinge Ab
Livanova Plc
Medtronic
Alung Technologies, Inc.
Armstrong Medical
Besmed Health Business Corp.
Dragerwerk Ag & Co. Kgaa
Eurosets
F. Hoffmann-la Roche Ltd.
Fisher & Paykel Healthcare Limited
Fresenius Se & Co. Kgaa
Hamilton Medical
Nice Neotech Medical Systems Pvt.ltd.
Nipro
Pfizer Inc.
Resmed
Smiths Medical
Weinmann Emergency Medical Technology Gmbh+co. Kg
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Respiratory Distress Syndrome (ARDS) Treatment, market overview.
Chapter 2: Global Acute Respiratory Distress Syndrome (ARDS) Treatment market size in revenue.
Chapter 3: Detailed analysis of Acute Respiratory Distress Syndrome (ARDS) Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Respiratory Distress Syndrome (ARDS) Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acute Respiratory Distress Syndrome (ARDS) Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Overall Market Size
2.1 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size: 2024 VS 2032
2.2 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Respiratory Distress Syndrome (ARDS) Treatment Players in Global Market
3.2 Top Global Acute Respiratory Distress Syndrome (ARDS) Treatment Companies Ranked by Revenue
3.3 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acute Respiratory Distress Syndrome (ARDS) Treatment Companies in Global Market, by Revenue in 2024
3.5 Global Companies Acute Respiratory Distress Syndrome (ARDS) Treatment Product Type
3.6 Tier 1, Tier 2, and Tier 3 Acute Respiratory Distress Syndrome (ARDS) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acute Respiratory Distress Syndrome (ARDS) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Respiratory Distress Syndrome (ARDS) Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size Markets, 2024 & 2032
4.1.2 Oral
4.1.3 Intravenous Injection
4.1.4 Intramuscular Injection
4.2 Segmentation by Type - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue & Forecasts
4.2.1 Segmentation by Type - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2024 & 2032
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 Segmentation by Application - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue & Forecasts
5.2.1 Segmentation by Application - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2024 & 2032
6.2 By Region - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue & Forecasts
6.2.1 By Region - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2020-2025
6.2.2 By Region - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2026-2032
6.2.3 By Region - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2020-2032
6.3.2 United States Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.3.3 Canada Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.3.4 Mexico Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2020-2032
6.4.2 Germany Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.4.3 France Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.4.4 U.K. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.4.5 Italy Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.4.6 Russia Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.4.7 Nordic Countries Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.4.8 Benelux Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2020-2032
6.5.2 China Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.5.3 Japan Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.5.4 South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.5.5 Southeast Asia Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.5.6 India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2020-2032
6.6.2 Brazil Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.6.3 Argentina Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, 2020-2032
6.7.2 Turkey Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.7.3 Israel Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.7.4 Saudi Arabia Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
6.7.5 UAE Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, 2020-2032
7 Companies Profiles
7.1 Gilead Sciences Inc.
7.1.1 Gilead Sciences Inc. Corporate Summary
7.1.2 Gilead Sciences Inc. Business Overview
7.1.3 Gilead Sciences Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.1.4 Gilead Sciences Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.1.5 Gilead Sciences Inc. Key News & Latest Developments
7.2 Terumo Corporation
7.2.1 Terumo Corporation Corporate Summary
7.2.2 Terumo Corporation Business Overview
7.2.3 Terumo Corporation Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.2.4 Terumo Corporation Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.2.5 Terumo Corporation Key News & Latest Developments
7.3 Getinge Ab
7.3.1 Getinge Ab Corporate Summary
7.3.2 Getinge Ab Business Overview
7.3.3 Getinge Ab Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.3.4 Getinge Ab Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.3.5 Getinge Ab Key News & Latest Developments
7.4 Livanova Plc
7.4.1 Livanova Plc Corporate Summary
7.4.2 Livanova Plc Business Overview
7.4.3 Livanova Plc Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.4.4 Livanova Plc Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.4.5 Livanova Plc Key News & Latest Developments
7.5 Medtronic
7.5.1 Medtronic Corporate Summary
7.5.2 Medtronic Business Overview
7.5.3 Medtronic Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.5.4 Medtronic Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.5.5 Medtronic Key News & Latest Developments
7.6 Alung Technologies, Inc.
7.6.1 Alung Technologies, Inc. Corporate Summary
7.6.2 Alung Technologies, Inc. Business Overview
7.6.3 Alung Technologies, Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.6.4 Alung Technologies, Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.6.5 Alung Technologies, Inc. Key News & Latest Developments
7.7 Armstrong Medical
7.7.1 Armstrong Medical Corporate Summary
7.7.2 Armstrong Medical Business Overview
7.7.3 Armstrong Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.7.4 Armstrong Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.7.5 Armstrong Medical Key News & Latest Developments
7.8 Besmed Health Business Corp.
7.8.1 Besmed Health Business Corp. Corporate Summary
7.8.2 Besmed Health Business Corp. Business Overview
7.8.3 Besmed Health Business Corp. Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.8.4 Besmed Health Business Corp. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.8.5 Besmed Health Business Corp. Key News & Latest Developments
7.9 Dragerwerk Ag & Co. Kgaa
7.9.1 Dragerwerk Ag & Co. Kgaa Corporate Summary
7.9.2 Dragerwerk Ag & Co. Kgaa Business Overview
7.9.3 Dragerwerk Ag & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.9.4 Dragerwerk Ag & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.9.5 Dragerwerk Ag & Co. Kgaa Key News & Latest Developments
7.10 Eurosets
7.10.1 Eurosets Corporate Summary
7.10.2 Eurosets Business Overview
7.10.3 Eurosets Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.10.4 Eurosets Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.10.5 Eurosets Key News & Latest Developments
7.11 F. Hoffmann-la Roche Ltd.
7.11.1 F. Hoffmann-la Roche Ltd. Corporate Summary
7.11.2 F. Hoffmann-la Roche Ltd. Business Overview
7.11.3 F. Hoffmann-la Roche Ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.11.4 F. Hoffmann-la Roche Ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.11.5 F. Hoffmann-la Roche Ltd. Key News & Latest Developments
7.12 Fisher & Paykel Healthcare Limited
7.12.1 Fisher & Paykel Healthcare Limited Corporate Summary
7.12.2 Fisher & Paykel Healthcare Limited Business Overview
7.12.3 Fisher & Paykel Healthcare Limited Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.12.4 Fisher & Paykel Healthcare Limited Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.12.5 Fisher & Paykel Healthcare Limited Key News & Latest Developments
7.13 Fresenius Se & Co. Kgaa
7.13.1 Fresenius Se & Co. Kgaa Corporate Summary
7.13.2 Fresenius Se & Co. Kgaa Business Overview
7.13.3 Fresenius Se & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.13.4 Fresenius Se & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.13.5 Fresenius Se & Co. Kgaa Key News & Latest Developments
7.14 Hamilton Medical
7.14.1 Hamilton Medical Corporate Summary
7.14.2 Hamilton Medical Business Overview
7.14.3 Hamilton Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.14.4 Hamilton Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.14.5 Hamilton Medical Key News & Latest Developments
7.15 Nice Neotech Medical Systems Pvt.ltd.
7.15.1 Nice Neotech Medical Systems Pvt.ltd. Corporate Summary
7.15.2 Nice Neotech Medical Systems Pvt.ltd. Business Overview
7.15.3 Nice Neotech Medical Systems Pvt.ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.15.4 Nice Neotech Medical Systems Pvt.ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.15.5 Nice Neotech Medical Systems Pvt.ltd. Key News & Latest Developments
7.16 Nipro
7.16.1 Nipro Corporate Summary
7.16.2 Nipro Business Overview
7.16.3 Nipro Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.16.4 Nipro Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.16.5 Nipro Key News & Latest Developments
7.17 Pfizer Inc.
7.17.1 Pfizer Inc. Corporate Summary
7.17.2 Pfizer Inc. Business Overview
7.17.3 Pfizer Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.17.4 Pfizer Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.17.5 Pfizer Inc. Key News & Latest Developments
7.18 Resmed
7.18.1 Resmed Corporate Summary
7.18.2 Resmed Business Overview
7.18.3 Resmed Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.18.4 Resmed Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.18.5 Resmed Key News & Latest Developments
7.19 Smiths Medical
7.19.1 Smiths Medical Corporate Summary
7.19.2 Smiths Medical Business Overview
7.19.3 Smiths Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.19.4 Smiths Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.19.5 Smiths Medical Key News & Latest Developments
7.20 Weinmann Emergency Medical Technology Gmbh+co. Kg
7.20.1 Weinmann Emergency Medical Technology Gmbh+co. Kg Corporate Summary
7.20.2 Weinmann Emergency Medical Technology Gmbh+co. Kg Business Overview
7.20.3 Weinmann Emergency Medical Technology Gmbh+co. Kg Acute Respiratory Distress Syndrome (ARDS) Treatment Major Product Offerings
7.20.4 Weinmann Emergency Medical Technology Gmbh+co. Kg Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in Global Market (2020-2025)
7.20.5 Weinmann Emergency Medical Technology Gmbh+co. Kg Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Opportunities & Trends in Global Market
Table 2. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Drivers in Global Market
Table 3. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Restraints in Global Market
Table 4. Key Players of Acute Respiratory Distress Syndrome (ARDS) Treatment in Global Market
Table 5. Top Acute Respiratory Distress Syndrome (ARDS) Treatment Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Share by Companies, 2020-2025
Table 8. Global Companies Acute Respiratory Distress Syndrome (ARDS) Treatment Product Type
Table 9. List of Global Tier 1 Acute Respiratory Distress Syndrome (ARDS) Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Respiratory Distress Syndrome (ARDS) Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2026-2032
Table 30. Gilead Sciences Inc. Corporate Summary
Table 31. Gilead Sciences Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 32. Gilead Sciences Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 33. Gilead Sciences Inc. Key News & Latest Developments
Table 34. Terumo Corporation Corporate Summary
Table 35. Terumo Corporation Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 36. Terumo Corporation Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 37. Terumo Corporation Key News & Latest Developments
Table 38. Getinge Ab Corporate Summary
Table 39. Getinge Ab Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 40. Getinge Ab Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 41. Getinge Ab Key News & Latest Developments
Table 42. Livanova Plc Corporate Summary
Table 43. Livanova Plc Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 44. Livanova Plc Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 45. Livanova Plc Key News & Latest Developments
Table 46. Medtronic Corporate Summary
Table 47. Medtronic Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 48. Medtronic Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 49. Medtronic Key News & Latest Developments
Table 50. Alung Technologies, Inc. Corporate Summary
Table 51. Alung Technologies, Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 52. Alung Technologies, Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 53. Alung Technologies, Inc. Key News & Latest Developments
Table 54. Armstrong Medical Corporate Summary
Table 55. Armstrong Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 56. Armstrong Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 57. Armstrong Medical Key News & Latest Developments
Table 58. Besmed Health Business Corp. Corporate Summary
Table 59. Besmed Health Business Corp. Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 60. Besmed Health Business Corp. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 61. Besmed Health Business Corp. Key News & Latest Developments
Table 62. Dragerwerk Ag & Co. Kgaa Corporate Summary
Table 63. Dragerwerk Ag & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 64. Dragerwerk Ag & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 65. Dragerwerk Ag & Co. Kgaa Key News & Latest Developments
Table 66. Eurosets Corporate Summary
Table 67. Eurosets Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 68. Eurosets Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 69. Eurosets Key News & Latest Developments
Table 70. F. Hoffmann-la Roche Ltd. Corporate Summary
Table 71. F. Hoffmann-la Roche Ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 72. F. Hoffmann-la Roche Ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 73. F. Hoffmann-la Roche Ltd. Key News & Latest Developments
Table 74. Fisher & Paykel Healthcare Limited Corporate Summary
Table 75. Fisher & Paykel Healthcare Limited Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 76. Fisher & Paykel Healthcare Limited Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 77. Fisher & Paykel Healthcare Limited Key News & Latest Developments
Table 78. Fresenius Se & Co. Kgaa Corporate Summary
Table 79. Fresenius Se & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 80. Fresenius Se & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 81. Fresenius Se & Co. Kgaa Key News & Latest Developments
Table 82. Hamilton Medical Corporate Summary
Table 83. Hamilton Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 84. Hamilton Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 85. Hamilton Medical Key News & Latest Developments
Table 86. Nice Neotech Medical Systems Pvt.ltd. Corporate Summary
Table 87. Nice Neotech Medical Systems Pvt.ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 88. Nice Neotech Medical Systems Pvt.ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 89. Nice Neotech Medical Systems Pvt.ltd. Key News & Latest Developments
Table 90. Nipro Corporate Summary
Table 91. Nipro Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 92. Nipro Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 93. Nipro Key News & Latest Developments
Table 94. Pfizer Inc. Corporate Summary
Table 95. Pfizer Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 96. Pfizer Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 97. Pfizer Inc. Key News & Latest Developments
Table 98. Resmed Corporate Summary
Table 99. Resmed Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 100. Resmed Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 101. Resmed Key News & Latest Developments
Table 102. Smiths Medical Corporate Summary
Table 103. Smiths Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 104. Smiths Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 105. Smiths Medical Key News & Latest Developments
Table 106. Weinmann Emergency Medical Technology Gmbh+co. Kg Corporate Summary
Table 107. Weinmann Emergency Medical Technology Gmbh+co. Kg Acute Respiratory Distress Syndrome (ARDS) Treatment Product Offerings
Table 108. Weinmann Emergency Medical Technology Gmbh+co. Kg Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (US$, Mn) & (2020-2025)
Table 109. Weinmann Emergency Medical Technology Gmbh+co. Kg Key News & Latest Developments
List of Figures
Figure 1. Acute Respiratory Distress Syndrome (ARDS) Treatment Product Picture
Figure 2. Acute Respiratory Distress Syndrome (ARDS) Treatment Segment by Type in 2024
Figure 3. Acute Respiratory Distress Syndrome (ARDS) Treatment Segment by Application in 2024
Figure 4. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in 2024
Figure 9. Segmentation by Type � Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
Figure 13. By Region - Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
Figure 14. By Country - North America Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
Figure 15. United States Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
Figure 19. Germany Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 20. France Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
Figure 27. China Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 31. India Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
Figure 33. Brazil Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share, 2020-2032
Figure 36. Turkey Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue, (US$, Mn), 2020-2032
Figure 40. Gilead Sciences Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Terumo Corporation Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Getinge Ab Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Livanova Plc Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Medtronic Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Alung Technologies, Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Armstrong Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Besmed Health Business Corp. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Dragerwerk Ag & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Eurosets Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. F. Hoffmann-la Roche Ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Fisher & Paykel Healthcare Limited Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Fresenius Se & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Hamilton Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Nice Neotech Medical Systems Pvt.ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Nipro Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Pfizer Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. Resmed Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 58. Smiths Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 59. Weinmann Emergency Medical Technology Gmbh+co. Kg Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
